Skip to main content
. 2021 Jul 9;49(6):1313–1318. doi: 10.1007/s15010-021-01657-y

Table 1.

Baseline characteristics

Conventional treatment (n = 32) Monoclonal antibodies (n = 11)
Demographics and history
 Sex
  Female, n (%) 21 (65.6) 7 (63.6)
  Male, n (%) 11 (34.4) 4 (36.4)
 Mean age, years (SD) 71.9 (13.4) 71.1 (13.7)
Risk factors, n (%)
 Diabetes mellitus 11 (34.4) 5 (45.5)
 Obesity 7 (21.9) 2 (18.2)
 Immunosuppression/active cancer 5 (15.6) 2 (18.2)
 Chronic lung disease 4 (12.5) 4 (36.4)
  Home oxygen therapy 0 2 (18.2)
 Cardiovascular diseases 20 (62.5) 10 (90.9)
Primary admission department, n (%)
 Trauma surgery 10 (31.3) 0
 Neurosurgery 8 (25.0) 5 (45.5)
 Orthopedics 2 (6.3) 0
 Visceral surgery 3 (9.4) 3 (27.3)
 Vascular surgery 0 1 (9.1)
 Pneumology 0 1 (9.1)
 Gastroenterology 1 (3.1) 1 (9.1)
 Neurology 1 (3.1) 0
 Ophthalmology 1 (3.1) 0
 Psychiatry 4 (12.5) 0
 Gynecology and obstetrics 2 (6.3) 0

SD standard deviation